Yingke Capital

Type

Venture Capital

Status

Active

Location

Fuzhou, China

Total investments

86

Average round size

159M

Portfolio companies

77

Rounds per year

6.14

Lead investments

23

Follow on index

0.10

Exits

13

Areas of investment
BiotechnologyE-CommerceInformation TechnologyHealth CareManufacturingMedicalPharmaceuticalElectronicsBiopharmaElectric Vehicle

Summary

In 2006 was created Yingke Capital, which is appeared as VC.

The high activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 66 percentage points more often commits exit comparing to other organizations. This Yingke Capital works on 15 percentage points less the average amount of lead investments comparing to the other organizations. When the investment is from Yingke Capital the average startup value is more than 1 billion dollars.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Yingke Capital, startups are often financed by Zhongtai Chuanghui Equity Investment Fund, Xiaomi, Warmsun Holding Group. The meaningful sponsors for the fund in investment in the same round are Yueyin Venture Capital, Tigermed, TF Capital. In the next rounds fund is usually obtained by Tianjin Haida Venture Capital Management, Shenzhen Capital Group, Share Capital.

The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Biotechnology, Biopharma. Among the various public portfolio startups of the fund, we may underline Royole Corporation, Zelgen, Haihe Biopharma Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesSemiconductorsManufacturingDeep Tech

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
86
Lead investments
23
Exits
13
Rounds per year
6.14
Follow on index
0.10
Investments by industry
  • Health Care (27)
  • Biotechnology (21)
  • Manufacturing (17)
  • Medical (17)
  • Pharmaceutical (12)
  • Show 93 more
Investments by region
  • China (77)
  • United States (6)
  • Taiwan (1)
Peak activity year
2021
Number of Unicorns
5
Number of Decacorns
5
Number of Minotaurs
3

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
187M
Group Appearance index
0.56
Avg. company exit year
10
Avg. multiplicator
0.01
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Davinci Tech 19 Jul 2021 Robotics, Autonomous Vehicles, Electric Vehicle Seed Beijing, Beijing, China
SolarSpace 01 Nov 2022 Renewable Energy, Solar Early Stage Venture 463M Jiangsu, Xuzhou, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.